Kennedy Capital Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.72M | Sell |
|
|||||
|
2025
Q1 | $6.38M | Buy |
|
|||||
|
2024
Q4 | $4.93M | Buy |
|
|||||
|
2024
Q3 | $3.57M | Buy |
|
|||||
|
2024
Q2 | $3.92M | Sell |
|
|||||
|
2024
Q1 | $4.58M | Buy |
|
|||||
|
2023
Q4 | $2.82M | Sell |
|
|||||
|
2023
Q3 | $5.8M | Sell |
|
|||||
|
2023
Q2 | $5.34M | Buy |
|
|||||
|
2023
Q1 | $4.72M | Buy |
|
|||||
|
2022
Q4 | $2.74M | Sell |
|
|||||
|
2022
Q3 | $2.54M | Buy |
|
|||||
|
2022
Q2 | $389K | Buy |
|